Concept information
Preferred term
Monoclonal antibody preparation
Type
-
http://www.irandoc.ac.ir/onto/irandoc-meta/Concept
Broader concept
Narrower concepts
- Abciximab
- Adalimumab (product)
- Basiliximab
- Belimumab
- Brolucizumab-containing product
- Canakinumab
- Caplacizumab-containing product
- Certolizumab pegol (product)
- Daclizumab
- Denosumab (product)
- Eculizumab (product)
- Erenumab-containing product
- Fremanezumab-containing product
- Galcanezumab-containing product
- Golimumab
- Infliximab
- Lanadelumab-containing product
- Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)
- Natalizumab (product)
- Omalizumab (product)
- Palivizumab
- Product containing alirocumab (medicinal product)
- Product containing benralizumab
- Product containing bezlotoxumab (medicinal product)
- Product containing brodalumab (medicinal product)
- Product containing burosumab (medicinal product)
- Product containing crizanlizumab (medicinal product)
- Product containing dupilumab (medicinal product)
- Product containing emapalumab (medicinal product)
- Product containing emicizumab (medicinal product)
- Product containing evolocumab (medicinal product)
- Product containing guselkumab (medicinal product)
- Product containing ibalizumab (medicinal product)
- Product containing idarucizumab (medicinal product)
- Product containing ixekizumab (medicinal product)
- Product containing mepolizumab (medicinal product)
- Product containing obiltoxaximab (medicinal product)
- Product containing ocrelizumab (medicinal product)
- Product containing ravulizumab (medicinal product)
- Product containing reslizumab (medicinal product)
- Product containing risankizumab (medicinal product)
- Product containing romosozumab (medicinal product)
- Product containing sarilumab
- Product containing tildrakizumab (medicinal product)
- Ranibizumab (product)
- Secukinumab
- Siltuximab
- Technetium (99m-Tc) arcitumomab-containing product in parenteral dose form
- Tocilizumab (product)
- Ustekinumab (product)
- Vedolizumab
Has active ingredient
Is a
In other languages
-
Persian
URI
http://www.irandoc.acir/onto/irandoc/108807002
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}